Oliman, Bahira .

HRN: 19-48-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/14/2025
07/20/2025
IVT
500mg
OD
Complicated UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines